Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese

[1] Gholam P(2002)Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery Obes Surg 12 49-51

[2] Kotler D(2004)Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease Hepatology 40 475-83

[3] Flancbaum L(2000)Liver fibrosis in overweight patients Gastroenterology 118 1117-23

[4] Abrams GA(2013)The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors Acta Cir Bras 28 788-93

[5] Kunde SS(2015)Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 149 389-97

[6] Lazenby AJ(2015)Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up Hepatology 61 1547-54

[7] Ratziu V(2011)Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 274-85

[8] Giral P(2012)Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment Dig Dis 30 158-62

[9] Charlotte F(2014)Hepatic pathology among patients with known liver disease undergoing bariatric surgery: observations and a perspective from the Longitudinal Assessment of Bariatric Surgery (LABS) study Semin Liver Dis 34 98-107

[10] Feijo SG(2014)Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis World J Hepatol 20 475-85

[1] Gholam P(2002)Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery Obes Surg 12 49-51

[2] Kotler D(2004)Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease Hepatology 40 475-83

[3] Flancbaum L(2000)Liver fibrosis in overweight patients Gastroenterology 118 1117-23

[4] Abrams GA(2013)The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors Acta Cir Bras 28 788-93

[5] Kunde SS(2015)Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 149 389-97

[6] Lazenby AJ(2015)Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up Hepatology 61 1547-54

[7] Ratziu V(2011)Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 274-85

[8] Giral P(2012)Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment Dig Dis 30 158-62

[9] Charlotte F(2014)Hepatic pathology among patients with known liver disease undergoing bariatric surgery: observations and a perspective from the Longitudinal Assessment of Bariatric Surgery (LABS) study Semin Liver Dis 34 98-107

[10] Feijo SG(2014)Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis World J Hepatol 20 475-85